• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性细菌性前列腺炎分离的尿路病原体的流行病学特征及耐药模式。

Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.

机构信息

Department of Urology, Santa Chiara Hospital, Trento, 38123, Italy.

出版信息

J Microbiol. 2011 Jun;49(3):448-54. doi: 10.1007/s12275-011-0391-z. Epub 2011 Jun 30.

DOI:10.1007/s12275-011-0391-z
PMID:21717331
Abstract

Chronic bacterial prostatitis (CBP) is, usually, caused by uropathogens, especially gram-negative bacilli, although infection is sometimes due to Gram-positive and atypical microorganisms. A recent increasing in prevalence of Gram-positive strains has been reported. The aim of this study was to explore the epidemiological features and resistance rates in uropathogens isolated from CBP outpatients in last 10 years. All consecutive outpatients with demonstrated CBP attending a single Sexually Transmitted Disease centre from January 1997 and December 2008, were enrolled and underwent microbiological cultures in first void early morning urine, midstream urine, expressed prostatic secretion, and post prostate massage urine. Prevalence of different bacterial strains was stratified in four different periods: 1997-1999, 2000-2002, 2003-2005, 2006-2008. Any changes observed in epidemiological features and resistance rates in uropathogens over the whole study period have been analyzed. The present study has been planned, thus, as in vitro study. From 6,221 patients, 4,601 Gram-positive and 1,620 Gram-negative bacterial strains have been isolated. Enterococcus faecalis and Escherichia coli strains are the first and second frequent pathogens found, respectively. Significant differences between E. faecalis prevalence in the 1997-1999 and 2006-2008 periods were found. E. coli showed a significant difference between prevalence in 1997-1999 and 2006-2008 periods. Gram-positive organisms showed a decreasing of susceptibility to ciprofloxacin as well as Gram-negative strains, while a good susceptibility to the levofloxacin was evidenced. E. faecalis prevalence seemed to be raised in 2006-2008 periods. Moreover, a decreasing of activity of ciprofloxacin and a good activity profile of levofloxacin have been reported.

摘要

慢性细菌性前列腺炎(CBP)通常由尿路病原体引起,特别是革兰氏阴性杆菌,尽管感染有时也由革兰氏阳性和非典型微生物引起。最近有报道称,革兰氏阳性菌株的流行率有所增加。本研究旨在探讨过去 10 年来 CBP 门诊患者分离的尿路病原体的流行病学特征和耐药率。1997 年 1 月至 2008 年 12 月,连续就诊于一家性传播疾病中心的 CBP 门诊患者均纳入本研究,并进行了清晨首次排尿中段尿、前列腺按摩后尿液和前列腺分泌物的微生物培养。根据不同的时间段,将不同细菌菌株的流行率分为四个不同时期:1997-1999 年、2000-2002 年、2003-2005 年、2006-2008 年。分析了整个研究期间尿路病原体的流行病学特征和耐药率的变化。本研究是一项体外研究。从 6221 例患者中分离出 4601 株革兰氏阳性菌和 1620 株革兰氏阴性菌。粪肠球菌和大肠埃希菌是最常见的病原体,分别位列第一和第二位。1997-1999 年和 2006-2008 年期间,粪肠球菌的流行率存在显著差异。1997-1999 年和 2006-2008 年期间,大肠埃希菌的流行率也存在显著差异。革兰氏阳性菌对环丙沙星的敏感性以及革兰氏阴性菌的敏感性均有所下降,而对左氧氟沙星的敏感性较好。2006-2008 年期间,粪肠球菌的流行率似乎有所上升。此外,环丙沙星的活性下降,左氧氟沙星的活性谱良好。

相似文献

1
Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.慢性细菌性前列腺炎分离的尿路病原体的流行病学特征及耐药模式。
J Microbiol. 2011 Jun;49(3):448-54. doi: 10.1007/s12275-011-0391-z. Epub 2011 Jun 30.
2
Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in rizgary hospital - Erbil.在埃尔比勒的 Rizgary 医院收到的尿液标本中分离出的细菌病原体的流行情况和药敏性。
J Infect Public Health. 2019 May-Jun;12(3):330-336. doi: 10.1016/j.jiph.2018.11.005. Epub 2018 Dec 3.
3
IMPACT OF MICROBIOLOGICAL CHANGES ON SPONTANEOUS BACTERIAL PERITONITIS IN THREE DIFFERENT PERIODS OVER 17 YEARS.17年间三个不同时期微生物变化对自发性细菌性腹膜炎的影响
Arq Gastroenterol. 2018 Jan-Mar;55(1):23-27. doi: 10.1590/S0004-2803.201800000-08.
4
[Pathogens of prostatitis and their drug resistance: an epidemiological survey].[前列腺炎的病原体及其耐药性:一项流行病学调查]
Zhonghua Nan Ke Xue. 2013 Oct;19(10):912-7.
5
Common uropathogens and their antibiotic susceptibility pattern among diabetic patients.糖尿病患者常见尿路病原体及其抗生素敏感性模式。
BMC Infect Dis. 2019 Jan 10;19(1):43. doi: 10.1186/s12879-018-3669-5.
6
Antimicrobial susceptibility patterns of uropathogens isolated from pregnant women in KwaZulu-Natal Province: 2011 - 2016.夸祖鲁-纳塔尔省孕妇分离尿路病原体的抗菌药敏模式:2011-2016 年。
S Afr Med J. 2020 Aug 31;110(9):872-876. doi: 10.7196/SAMJ.2020.v110i9.14468.
7
[In vitro antibiotic susceptibility to fluoroquinolones].[氟喹诺酮类药物的体外抗生素敏感性]
Arch Soc Esp Oftalmol. 2012 Mar;87(3):72-8. doi: 10.1016/j.oftal.2011.06.023. Epub 2011 Dec 29.
8
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].[普卢利沙星、左氧氟沙星和环丙沙星对尿路病原体的体外活性]
Infez Med. 2006 Mar;14(1):24-8.
9
Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.口服左氧氟沙星500毫克,每日一次,用于治疗慢性细菌性前列腺炎。
Int J Antimicrob Agents. 2008 Aug;32(2):145-53. doi: 10.1016/j.ijantimicag.2008.03.014. Epub 2008 Jun 20.
10
ANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI.内罗毕肯雅塔国家医院就诊患者中引起尿路感染的微生物的抗生素敏感性
East Afr Med J. 2015 Jul;92(7):333-337.

引用本文的文献

1
Could Urology's Antimicrobial Stewardship Be Enhanced by the Routine Use of the Meares and Stamey Test?常规使用米尔斯和斯塔米试验能否加强泌尿外科的抗菌药物管理?
Diagnostics (Basel). 2025 Apr 14;15(8):1002. doi: 10.3390/diagnostics15081002.
2
Pathogen Detection and Diagnostic Scenarios in Chronic Prostatitis.慢性前列腺炎中的病原体检测与诊断方案
Diagnostics (Basel). 2025 Mar 18;15(6):762. doi: 10.3390/diagnostics15060762.
3
Prevalence and antibiotic susceptibility patterns of uropathogens in men with prostate cancer and benign prostate hyperplasia from Southwestern Nigeria.

本文引用的文献

1
Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications.慢性细菌性前列腺炎(NIH-II型)中的生物膜与前列腺钙化
FEMS Immunol Med Microbiol. 2010 Aug;59(3):337-44. doi: 10.1111/j.1574-695X.2010.00659.x. Epub 2010 Feb 17.
2
Chronic prostatitis: management strategies.慢性前列腺炎:管理策略
Drugs. 2009;69(1):71-84. doi: 10.2165/00003495-200969010-00005.
3
Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status.慢性细菌性前列腺炎(美国国立卫生研究院II型):诊断、治疗及对生育状况的影响
来自尼日利亚西南部的前列腺癌和良性前列腺增生男性患者的尿路病原体流行情况和抗生素敏感性模式。
BMC Microbiol. 2024 Sep 21;24(1):361. doi: 10.1186/s12866-024-03524-w.
4
Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis.噬菌体溶菌酶成功用于治疗慢性盆腔疼痛综合征/慢性细菌性前列腺炎。
Front Med (Lausanne). 2023 Aug 15;10:1238147. doi: 10.3389/fmed.2023.1238147. eCollection 2023.
5
[Antibiotic resistance changes in episodes of symptomatic bacteriospermia: development in a health area of southeast Spain].[有症状菌尿症发作时的抗生素耐药性变化:西班牙东南部一个健康区域的发展情况]
Rev Esp Quimioter. 2023 Jun;36(3):275-281. doi: 10.37201/req/117.2022. Epub 2023 Mar 4.
6
[Microbial etiology of bacterial chronic prostatitis: systematic review].[细菌性慢性前列腺炎的微生物病因学:系统评价]
Rev Esp Quimioter. 2023 Apr;36(2):144-151. doi: 10.37201/req/099.2022. Epub 2023 Jan 9.
7
One, No One and One Hundred Thousand: Patterns of chronic prostatic inflammation and infection.《一个、没人和十万:慢性前列腺炎与感染的模式》
Exp Ther Med. 2021 Sep;22(3):966. doi: 10.3892/etm.2021.10398. Epub 2021 Jul 7.
8
Pharmacological Interventions for Bacterial Prostatitis.细菌性前列腺炎的药物治疗干预措施。
Front Pharmacol. 2020 Apr 30;11:504. doi: 10.3389/fphar.2020.00504. eCollection 2020.
9
Current Knowledge of the Potential Links between Inflammation and Prostate Cancer.当前对炎症与前列腺癌之间潜在联系的认识。
Int J Mol Sci. 2019 Aug 6;20(15):3833. doi: 10.3390/ijms20153833.
10
Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapy.前列腺炎中的炎症机制与氧化应激:抗氧化治疗的潜在作用
Res Rep Urol. 2018 Sep 17;10:75-87. doi: 10.2147/RRU.S170400. eCollection 2018.
Andrologia. 2008 Apr;40(2):100-4. doi: 10.1111/j.1439-0272.2007.00827.x.
4
Management of bacterial prostatitis: what's new?细菌性前列腺炎的管理:有哪些新进展?
BJU Int. 2008 Mar;101 Suppl 3:7-10. doi: 10.1111/j.1464-410X.2008.07495.x.
5
Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis.非传统细菌性尿路病原体在慢性前列腺炎管理中的临床意义
J Urol. 2008 Apr;179(4):1391-5. doi: 10.1016/j.juro.2007.11.081. Epub 2008 Mar 4.
6
Epidemiology of prostatitis.前列腺炎的流行病学
Int J Antimicrob Agents. 2008 Feb;31 Suppl 1(Suppl 1):S85-90. doi: 10.1016/j.ijantimicag.2007.08.028. Epub 2007 Dec 31.
7
Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005.1994 - 2005年住院尿路感染患者尿路病原体的谱型及抗生素耐药性
Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S25-34. doi: 10.1016/j.ijantimicag.2007.07.029. Epub 2007 Nov 7.
8
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.慢性前列腺炎样症状对一大群男性生活质量的影响。
BJU Int. 2007 Dec;100(6):1307-11. doi: 10.1111/j.1464-410X.2007.07250.x. Epub 2007 Oct 17.
9
Conventional bacteriology in prostatitis patients: microbiological bias, problems and epidemiology on 1686 microbial isolates.前列腺炎患者的传统细菌学:1686株微生物分离株的微生物学偏差、问题及流行病学
Arch Ital Urol Androl. 2007 Jun;79(2):71-5.
10
Prostatitis: Infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key.前列腺炎:感染、神经肌肉疾病还是疼痛综合征?正确的患者分类是关键。
Cleve Clin J Med. 2007 May;74 Suppl 3:S63-71. doi: 10.3949/ccjm.74.suppl_3.s63.